AZD6738 First Time in Patient Multiple Ascending Dose Study
Conditions
- 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL),
- Prolymphocytic Leukaemia (PLL)
- B Cell Lymphomas
Interventions
- DRUG: Administration of AZD6738
Sponsor
AstraZeneca
Collaborators